Browsing: Evaluation

Judge ruled Jeanine John Taele, discovered with firearm days before Trump visit, was unfit to face felony charge

The U.S. Food and Drug Administration (FDA) has cleared for marketing an innovative blood test with underlying technology invented at Washington University School of Medicine in St. Louis for the early diagnosis of Alzheimer’s disease. The test, known as PrecivityAD2, was developed and validated by C2N Diagnostics, a WashU startup company

The US Department of Health and Human Services (HHS) has appointed Duvi Honig, Founder and CEO of the Orthodox Jewish Chamber of Commerce and a longtime advocate for patients with Lyme disease and other chronic conditions, to serve as an Evaluation Panelist for the TOPx HHS Tech Sprint for AI and Invisible Illness

Self-management refers to the ability of people living with chronic conditions to manage symptoms, treatment, and the physical, psychological, and lifestyle impacts of their disease.1,2 It aims to promote patient independence and is ideally supported by others, such as healthcare professionals, patient organisations, and family members.3 For people living with rheumatic and musculoskeletal diseases (RMD),…